Antitumor agents 269. Non-aromatic ring-A neotanshinlactone analog, TNO, as a new class of potent antitumor agents

Bioorganic and Medicinal Chemistry Letters

Volumn 19, Issue 22, 2009, Pages 6289-6292

  Dong, Yizhou ^a   Shi, Qian ^a   Nakagawa Goto, Kyoko ^a   Wu, Pei Chi ^a   Bastow, Kenneth F ^a   Morris Natschke, Susan L ^a   Lee, Kuo Hsiung ^a  

^a University of North Carolina   (United States)

Author keywords

Breast cancer; Cytotoxicity; Tetrahydronaphthalene 1 ol (TNO) analogs; Tetrahydroneotanshinlactone (TNT) analogs

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOHEXENE DERIVATIVE; NEOTANSHINLATONE I; TANSHINONE I; TANSHINONE IIA; TETRAHYDRONAPHTHALENE 1 OL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IN VITRO STUDY;

ANIMALS; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; DRUG DESIGN; DRUG RESISTANCE, NEOPLASM; DRUG SCREENING ASSAYS, ANTITUMOR; FURANS; HUMANS; LUNG NEOPLASMS; MICE; MICE, NUDE; MOLECULAR STRUCTURE; PYRIDAZINES; PYRONES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 71149104734     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2009.09.092     Document Type: Article

References (16)

1. Balunas M.J., and Kinghorn A.D. Life Sci. 78 (2005) 431
2. Parkin D.M. Lancet Oncol. 2 (2001) 533
3. Cancer Facts & Figures. American Cancer Society, 2009.
4. Tan G., Gyllenhaal C., and Soejarto D.D. Curr. Drug Targets 7 (2006) 265
5. Paterson I., and Anderson Edward A. Science 310 (2005) 451
6. Rishton G.M. Am. J. Cardiol. 101 (2008) 43D
7. Saklani A., and Kutty S.K. Drug Discovery Today 13 (2008) 161
8. Wang X., Morris-Natschke S.L., and Lee K.H. Med. Res. Rev. 27 (2007) 133
9. Lee C.-Y., Sher H.-F., Chen H.-W., Liu C.-C., Chen C.-H., Lin C.-S., Yang P.-C., Tsay H.-S., and Chen J.J.W. Mol. Cancer Ther. 7 (2008) 3527
10. Sung H.J., Choi S.M., Yoon Y., and An K.S. Exp. Mol. Med. 31 (1999) 174
11. Wang X., Bastow K.F., Sun C.M., Lin Y.L., Yu H.J., Don M.J., Wu T.S., Nakamura S., and Lee K.H. J. Med. Chem. 47 (2004) 5816
12. Fischer C., and Fu G.C. J. Am. Chem. Soc. 127 (2005) 4594
13. Danheiser R.L., Casebier D.S., and Firooznia F. J. Org. Chem. 60 (1995) 8341
14. Glover S.A., Golding S.L., Goosen A., and McCleland C.W. J. Chem. Soc., Perkin Trans. 1 (1981) 842
15. 2), 2.11
16. Wang X., Nakagawa-Goto K., Bastow K.F., Don M.J., Lin Y.L., Wu T.S., and Lee K.H. J. Med. Chem. 49 (2006) 5631